3-[(1S,3R,6R,7R,10R,11S,14S,16R)-14-[(2R,4R,5S,6R)-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadecan-6-yl]-2H-furan-5-one

Details

Top
Internal ID 19c77911-2b9e-4651-84ce-2c825856430c
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroid lactones > Cardenolides and derivatives > Cardenolide glycosides and derivatives
IUPAC Name 3-[(1S,3R,6R,7R,10R,11S,14S,16R)-14-[(2R,4R,5S,6R)-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadecan-6-yl]-2H-furan-5-one
SMILES (Canonical) CC1C(C(CC(O1)OC2CCC3(C(C2)CCC45C3CCC6(C4(O5)CCC6C7=CC(=O)OC7)C)C)OC)OC8C(C(C(C(O8)CO)O)O)O
SMILES (Isomeric) C[C@@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@]45[C@@H]3CC[C@]6([C@]4(O5)CC[C@@H]6C7=CC(=O)OC7)C)C)OC)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O
InChI InChI=1S/C36H54O12/c1-18-31(47-32-30(41)29(40)28(39)24(16-37)46-32)23(42-4)15-27(44-18)45-21-6-9-33(2)20(14-21)5-11-35-25(33)8-10-34(3)22(7-12-36(34,35)48-35)19-13-26(38)43-17-19/h13,18,20-25,27-32,37,39-41H,5-12,14-17H2,1-4H3/t18-,20-,21+,22-,23-,24-,25-,27+,28-,29+,30-,31+,32+,33+,34-,35+,36-/m1/s1
InChI Key CIZSXZUKRRWNOP-NCCHFIKYSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C36H54O12
Molecular Weight 678.80 g/mol
Exact Mass 678.36152715 g/mol
Topological Polar Surface Area (TPSA) 166.00 Ų
XlogP 1.60
Atomic LogP (AlogP) 2.12
H-Bond Acceptor 12
H-Bond Donor 4
Rotatable Bonds 7

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 3-[(1S,3R,6R,7R,10R,11S,14S,16R)-14-[(2R,4R,5S,6R)-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadecan-6-yl]-2H-furan-5-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7913 79.13%
Caco-2 - 0.8686 86.86%
Blood Brain Barrier - 0.7500 75.00%
Human oral bioavailability - 0.7000 70.00%
Subcellular localzation Mitochondria 0.7600 76.00%
OATP2B1 inhibitior - 0.8679 86.79%
OATP1B1 inhibitior + 0.8837 88.37%
OATP1B3 inhibitior + 0.9497 94.97%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior + 0.7933 79.33%
P-glycoprotein inhibitior + 0.7356 73.56%
P-glycoprotein substrate + 0.6591 65.91%
CYP3A4 substrate + 0.7256 72.56%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8875 88.75%
CYP3A4 inhibition - 0.9188 91.88%
CYP2C9 inhibition - 0.8145 81.45%
CYP2C19 inhibition - 0.8323 83.23%
CYP2D6 inhibition - 0.9291 92.91%
CYP1A2 inhibition - 0.8522 85.22%
CYP2C8 inhibition + 0.4458 44.58%
CYP inhibitory promiscuity - 0.8866 88.66%
UGT catelyzed + 0.9000 90.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6355 63.55%
Eye corrosion - 0.9865 98.65%
Eye irritation - 0.9266 92.66%
Skin irritation - 0.6591 65.91%
Skin corrosion - 0.9371 93.71%
Ames mutagenesis - 0.6454 64.54%
Human Ether-a-go-go-Related Gene inhibition + 0.7610 76.10%
Micronuclear - 0.6900 69.00%
Hepatotoxicity - 0.7000 70.00%
skin sensitisation - 0.8863 88.63%
Respiratory toxicity + 0.6333 63.33%
Reproductive toxicity + 0.8556 85.56%
Mitochondrial toxicity + 0.6000 60.00%
Nephrotoxicity - 0.7072 70.72%
Acute Oral Toxicity (c) I 0.6868 68.68%
Estrogen receptor binding + 0.7188 71.88%
Androgen receptor binding + 0.7751 77.51%
Thyroid receptor binding - 0.6603 66.03%
Glucocorticoid receptor binding + 0.6321 63.21%
Aromatase binding + 0.6939 69.39%
PPAR gamma + 0.6838 68.38%
Honey bee toxicity - 0.6247 62.47%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity - 0.5100 51.00%
Fish aquatic toxicity + 0.9428 94.28%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.90% 91.11%
CHEMBL3137262 O60341 LSD1/CoREST complex 95.25% 97.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 94.86% 100.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 94.83% 96.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.34% 94.45%
CHEMBL1293249 Q13887 Kruppel-like factor 5 90.45% 86.33%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.66% 95.56%
CHEMBL5608 Q16288 NT-3 growth factor receptor 88.23% 95.89%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 87.95% 94.00%
CHEMBL2581 P07339 Cathepsin D 87.34% 98.95%
CHEMBL253 P34972 Cannabinoid CB2 receptor 84.88% 97.25%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 84.32% 95.89%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 84.20% 97.14%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 83.81% 97.33%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 83.27% 85.14%
CHEMBL5255 O00206 Toll-like receptor 4 82.54% 92.50%
CHEMBL241 Q14432 Phosphodiesterase 3A 82.04% 92.94%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 81.75% 96.77%
CHEMBL226 P30542 Adenosine A1 receptor 81.07% 95.93%

Cross-Links

Top
PubChem 102484064
NPASS NPC219998